Newsroom
Sorted by: Latest
-
Esco Aster与Shine-On Biomedical签署外泌体临床cGMP生产合同,用于开发一种新型突破性的HLA-G靶向外泌体药物递送平台
新加坡--(BUSINESS WIRE)--(美国商业资讯)-- 立足于新加坡JTC LaunchPad的垂直整合细胞及衍生物CRDMO企业Esco Aster宣布,将为Shine-On Biomedical的HLA-G靶向外泌体项目提供CMC生产支持。Shine-On Biomedical于2023年委托Esco Aster开展cGMP服务,初期利用Esco Aster的细胞系平台进行高产外泌体开发。工艺开发、分析方法开发、配方开发、外泌体药物负载、GMP工程化运行及稳定性研究等技术报告,为Shine-On提交新药临床试验申请(IND)提供了支持。该IND申请已于2025年第一季度获得美国FDA批准。 此外,Esco Aster还根据Shine-On的指示,提供探索性外泌体载药可行性研究的技术服务。Shine-On Biomedical是一家新兴的基于外泌体的药物递送创新企业。 ShineOn的专有产品SOB100是一种HLA-G靶向外泌体药物递送载体,已通过美国FDA IND审查,并正在进行I期研究,使其成为同类首创的HLA-G靶向外泌体药物开发平台。 Shine-On Biome...
-
Latent Labs Announces Latent-X2: AI-Generated Antibodies With Drug-Like Developability and Low Ex Vivo Immunogenicity
LONDON & SAN FRANCISCO--(BUSINESS WIRE)--Today, Latent Labs announces Latent-X2, a frontier AI model that can design drug-like biologics without iteration. Drug hunters can use Latent Lab's AI platform, built on Latent-X2, to access difficult targets and accelerate development timelines by reducing wet lab work. The generated designs display drug-like properties including low ex vivo immunogenicity, significantly shortening the path from hit to clinical candidate. Alongside the release, Latent...
-
Volante Technologies Customers Successfully Navigate Critical Regulatory Deadlines for EU SEPA Instant and Global SWIFT Cross-Border Payments
LONDON--(BUSINESS WIRE)--Volante Technologies, the global leader in Payments as a Service (PaaS), today announced it has successfully upgraded its clients to meet the latest SEPA Instant Payments Regulation (IPR) and SWIFT SRG 2025 mandate, which came into effect October 9th and November 22nd, 2025, respectively. This announcement follows the major FedISO upgrade in July, which shifted trillions of dollars in payments to the new ISO 20022 messaging format. SEPA IPR is a significant European mil...
-
Royal London Asset Management Partners With Seismic to Transform How Client Relationships Deepen, Grow and Scale
LONDON--(BUSINESS WIRE)--Royal London Asset Management selected Seismic to enable its teams across sales, marketing, compliance, and client services....
-
Neuranics Selected for Scale Up Scotland 2.0 Ahead of the Next Phase of Growth
GLASGOW, Scotland--(BUSINESS WIRE)--Following a breakthrough year of technical progress and global recognition, Neuranics has been selected to take part in the 2026 Scale Up Scotland 2.0 programme, founded by Scottish entrepreneur and philanthropist Sir Tom Hunter. Scale Up Scotland 2.0 is designed to support founders as they transition from rapid innovation into sustained scale, with a focus on leadership depth, strategic clarity, and long-term value creation. Delivered by The Hunter Foundatio...
-
MUFG Bank, Ltd. announces Notice Regarding Changes of Representatives of the Board of Directors
TOKYO--(BUSINESS WIRE)--MUFG Bank announced the following changes in Representatives of the Board of Directors decided at today’s meeting of the Board of Directors. 1. Reasons for the Changes Changes of Representatives of the Board of Directors due to regular changes in corporate executives. 2. Changes effective in Representative of the Board of Directors (1) Effective as of April 1, 2026 Name New Position Former Position Naoki Hori Senior Advisor Chairman of the Board of Directors (Represent...
-
KKR and Premialab Announce A $220m Strategic Investment To Power Next Phase Of Global Growth
LONDON & DUBAI & HONG KONG--(BUSINESS WIRE)--Premialab, a global provider of data, analytics and risk management solutions for quantitative investing, today announces a significant $220m growth investment from funds and accounts managed by KKR, a leading global investment firm. Under the terms of the agreement, KKR will lead a significant growth investment alongside existing investor Balderton. Founded by Adrien Géliot and Pierre Trecourt in 2016, Premialab is a global platform focused on the ~...
-
TreeFrog Therapeutics Announces Changes to Executive Committee With the Arrival of Mark Rothera as Chief Executive Officer & Board Member to Spearhead Next Phase of Growth
BORDEAUX, France--(BUSINESS WIRE)--TreeFrog Therapeutics, a French biotech focused on bringing regenerative medicine to millions through their proprietary cell technology, C-Stem™ is delighted to announce the appointment of skilled biotech leader, Mark Rothera, as Chief Executive Officer and Board member. He succeeds Frédéric Desdouits, who is stepping down after five years in the role. In the new leadership configuration, co-founders Kévin Alessandri and Maxime Feyeux will transition from dail...
-
TREEFROG THERAPEUTICS ANNONCE DES CHANGEMENTS AU SEIN DE SON COMITE EXECUTIF AVEC LA NOMINATION DE MARK ROTHERA EN TANT QUE DIRECTEUR GENERAL POUR ACCELERER SA PROCHAINE PHASE DE CROISSANCE
BORDEAUX, France--(BUSINESS WIRE)--TreeFrog Therapeutics, une biotech française spécialisée dans la médecine régénérative et dédiée à rendre des thérapies cellulaires accessibles à des millions de patients grâce à sa technologie propriétaire C-Stem™, annonce la nomination de Mark Rothera en qualité de Directeur général et membre du Comité Stratégique. Il succède à Frédéric Desdouits, qui quitte ses fonctions après cinq années à ce poste. Dans cette nouvelle configuration du comité exécutif, les...
-
LEO Pharma Appoints Marika Murto to Lead Global Product Strategy
BALLERUP, Denmark--(BUSINESS WIRE)--LEO Pharma appoints Marika Murto to lead Global Product Strategy...